Table 1.
Patient characteristics.
| Patient | Sex | Age (years) | Time since stroke (days) | Lesion location | NIH Stroke Scale score | Treatment |
|---|---|---|---|---|---|---|
| 1 | M | 75 | 6 | C; L occipital | 1 | tPA + ST |
| 2 | M | 69 | 4 | L cerebellum, occipital | 0 | ST |
| 3 | M | 74 | 7 | C; R temporal, occipital | 1 | ST |
| 4 | F | 44 | 5 | C; L insula, frontal | 7 | ST |
| 5 | M | 45 | 3 | L cerebellum | 2 | ST |
| 6 | M | 55 | 3 | C; L MCA and MCA/PCA border | 0 | ST |
| 7 | M | 62 | 9 | C; L parietal | 0 | ST |
| 8 | M | 58 | 5 | C; L corticospinal tract, cerebellum | 0 | ST |
| 9 | F | 59 | 7 | C; R MCA | 2 | tPA + ST |
| 10 | M | 59 | 4 | C; R MCA | 2 | tPA + ST |
| 11 | M | 57 | 3 | SC; R pontine | 2 | ST |
| 12 | M | 63 | 5 | SC; R pontine | 0 | ST |
| 13 | F | 47 | 9 | C; R frontal | 0 | ST |
| 14 | F | 58 | 7 | C; L frontal | 1 | ST |
| 15 | F | 59 | 2 | C; L posterior insular, parietal | 2 | ST |
| 16 | F | 46 | 0 | R cerebellum | 2 | ST |
| 17 | M | 67 | 5 | SC; L lateral medulla | 0 | ST |
| 18 | M | 63 | 3 | C; R MCA | 0 | ST |
| 19 | F | 57 | 6 | L cerebellum | 1 | ST |
| 20 | M | 63 | 2 | SC; L posterior putamen | 2 | ST |
| 21 | M | 46 | 3 | C; R occipital | 0 | tPA + ST |
| 22 | F | 67 | 5 | C; R MCA | 4 | tPA + ST |
C, cortical; SC, subcortical; L, left; R, right; MCA, middle cerebral artery; PCA, posterior cerebral artery; tPA, tissue plasminogen activator; ST, standard of care stroke treatment (in most cases consisted of antiplatelet agent (e.g., aspirin, clopidogrel), anticoagulant (e.g. heparin, warfarin), anti-hypertensive (e.g., beta blocker, angiotensin-converting-enzyme inhibitor, and/or statin (e.g., simvastatin, pravastatin)).